AnaptysBio Stock (NASDAQ:ANAB), Quotes and News Summary

Q: What sector and industry does AnaptysBio (ANAB) operate in?

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	700.000 / 359.765K
Day Range	- - -
52 Wk Range	13.360 - 27.500
Market Cap	$711.651M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	22.27%
Days to Cover	11.26

Recent News

Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Avi Kapoor

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AnaptysBio (ANAB) stock?

You can purchase shares of AnaptysBio (NASDAQ: ANAB) through any online brokerage.

View our list of the best stock brokerages.

Who are AnaptysBio's (ANAB) competitors?

Other companies in AnaptysBio’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE), Tango Therapeutics (NASDAQ:TNGX) and Pharming (NASDAQ:PHAR).

What is the target price for AnaptysBio (ANAB) stock?

The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Leerink Partners on Tuesday, April 16, 2024. The analyst firm set a price target for 47.00 expecting ANAB to rise to within 12 months (a possible 80.42% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for AnaptysBio (ANAB)?

The stock price for AnaptysBio (NASDAQ: ANAB) is $26.05 last updated Today at May 10, 2024 at 7:06 AM EDT.

Does AnaptysBio (ANAB) pay a dividend?

There are no upcoming dividends for AnaptysBio.

When is AnaptysBio (NASDAQ:ANAB) reporting earnings?

AnaptysBio’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is AnaptysBio (ANAB) going to split?

There is no upcoming split for AnaptysBio.

What sector and industry does AnaptysBio (ANAB) operate in?

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-